The Journal of Cardiac Failure is a premier peer-reviewed publication dedicated to advancing the understanding and management of heart failure and associated cardiovascular conditions. Published by Churchill Livingstone Inc Medical Publishers, this esteemed journal serves as a vital resource for researchers, clinicians, and healthcare professionals committed to improving patient outcomes in cardiology. With a notable impact factor and ranked in the Q1 category of Cardiology and Cardiovascular Medicine, the journal is recognized for its rigorous scholarly contributions, currently holding a position within the top 15% of its field according to Scopus rankings. The journal spans a comprehensive range of topics, from clinical practices to innovative research in heart failure, fostering knowledge dissemination and collaboration among experts. As it converges from 1994 to 2024, the Journal of Cardiac Failure remains dedicated to publishing high-quality research that shapes the future of cardiovascular medicine, ensuring accessible and impactful scientific dialogue.

Clinical Hypertension is a premier journal dedicated to advancing the field of hypertension and cardiovascular health, published by SpringerNature. Since its transition to an Open Access model in 2014, the journal has opened doors for researchers globally to share their findings without barriers, aiming to foster collaboration and innovation in this vital area of medicine. With a current impact factor that positions it in the Q2 quartile for both Cardiology and Cardiovascular Medicine and Internal Medicine, Clinical Hypertension is recognized for its scholarly contributions, reflected in its Scopus rankings (Rank #100/387 in Cardiology and Rank #52/167 in Internal Medicine), which place it in the top percentiles of these competitive fields. Covering a diverse range of topics within hypertension research, it serves as an essential resource for clinicians, researchers, and students alike, promising to keep its audience informed of the latest developments and breakthroughs from its inception in 2017 through to 2024.

Journal of Clinical Hypertension, published by WILEY, is a leading open-access journal focused on advancing the understanding and treatment of hypertension and related cardiovascular conditions. With an ISSN of 1524-6175 and an E-ISSN of 1751-7176, the journal provides a vital platform for researchers, healthcare professionals, and students alike to disseminate high-quality, peer-reviewed research. Since transitioning to open access in 2021, it has increased its reach and accessibility, ensuring critical information is available to a broader audience. The journal holds an impressive position in the Scopus ranks, nestled within the Q2 quartile across key disciplines including Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Internal Medicine, indicating a strong impact on the scientific community. With articles converging from 2001 to 2024, it not only highlights contemporary developments but also contributes to the ongoing dialogue in the field. Researchers are encouraged to submit their findings on hypertension, treatment methodologies, and epidemiology to further enhance the collective knowledge in this crucial area of health.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

JOURNAL OF HUMAN HYPERTENSION, a prominent publication in the field of internal medicine, is dedicated to advancing the understanding of hypertension and its implications for human health. Published by SPRINGERNATURE in the United Kingdom, this esteemed journal has been a vital resource for researchers and clinicians since its inception in 1987, with a continuous commitment to disseminating high-quality, peer-reviewed research. With an impressive Q2 category rank in Internal Medicine and a Scopus rank of 53 out of 167, it occupies a crucial position within the academic community, reaching a 68th percentile ranking that underscores its significance. The journal aims to provide a platform for innovative studies and reviews, fostering knowledge that bridges basic science, clinical practice, and public health. Although it does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital information about hypertension is available to a broad spectrum of healthcare professionals and researchers. Explore the critical findings and groundbreaking research published in the JOURNAL OF HUMAN HYPERTENSION to stay at the forefront of hypertension studies.

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Clinical and Experimental Hypertension, published by Taylor & Francis Inc, is a crucial resource in the fields of internal medicine and physiology. With its inaugural publication dating back to 1978, this esteemed journal has successfully merged decades of research, providing a platform for the latest advancements in hypertension studies. Operating without an open access model, it is configured to serve a specialized audience of researchers, clinicians, and students who are dedicated to exploring innovative treatment modalities and understanding the complexities of hypertensive diseases. Ranked in the Q3 category in both Internal Medicine and Physiology, this journal accomplishes a commendable standing in the academic community, exemplified by its Scopus rankings which position it within the median percentile range in its field. By disseminating high-quality research and fostering scientific dialogue, Clinical and Experimental Hypertension plays a pivotal role in shaping contemporary understanding and clinical practices concerning hypertension management.

Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.

Pregnancy Hypertension – An International Journal of Women's Cardiovascular Health, published by Elsevier Science Ltd, is a leading platform dedicated to advancing the understanding of cardiovascular health in women during pregnancy and postpartum periods. With an ISSN of 2210-7789, this esteemed journal has distinguished itself in the fields of Internal Medicine and Obstetrics and Gynecology, maintaining a remarkable Q2 ranking in Internal Medicine and a prestigious Q1 ranking in Obstetrics and Gynecology as of 2023. It is recognized for its high-quality research, which fits within the top quartile of its categories, and spans from 2010 to 2024, reflecting its ongoing contribution to critical advancements in women's cardiovascular health. The journal is accessible to a global audience of researchers, practitioners, and students, emphasizing its commitment to promoting open scholarly communication, although it currently operates under traditional access. The publication serves as a crucial resource for those seeking to enhance their knowledge and practices related to the unique cardiovascular challenges faced by women during pregnancy, thereby fostering informed clinical approaches and improved health outcomes.

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.